When receiving a prescription for parenteral nutrition containing 25% glucose, what should the nurse do?

The correct approach when receiving a prescription for parenteral nutrition containing 25% glucose is to question the healthcare provider. Parenteral nutrition formulations typically contain varying concentrations of glucose, but a 25% glucose concentration is considered quite high and may exceed safe recommendations for many patients, particularly those who are unable to tolerate elevated glucose levels due to conditions like diabetes or compromised insulin response.

In clinical practice, glucose concentrations in parenteral nutrition are usually around 10% to 20%, with higher concentrations potentially leading to complications such as hyperglycemia, osmotic diuresis, and increased risk of infection due to elevated blood sugar levels. If the nurse questions the prescriber, they are protecting the patient from possible harm by ensuring that the prescribed therapy aligns with safe medical guidelines and the patient’s individual needs. This inquiry fosters communication and collaboration in the healthcare team, which is vital for patient safety.

Other actions, like confirming the prescription with the pharmacy, while also important in ensuring accuracy, do not directly address the clinical appropriateness of the treatment. Starting the infusion immediately without verifying the concentration or appropriateness could lead to significant complications for the patient. Documenting the order is necessary but does not involve critical assessment of the prescription's safety. Therefore,